Biogen Inc. (BIIB)
Biogen Max Pain By Strike
BIIB trades at $138.66, 10.9% above the near-term max pain of $125 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($65-$145), indicating stable market expectations. Key magnetic zone at 130 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Biogen Max Pain By Expiry
Max pain for BIIB shows stable levels around 125.73, reflecting balanced market expectations. The 64% spread signals divergent expectations across timeframes. Most levels below 138.66 may cap rallies. Strong magnetic level at 130 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 125 | -13.66 (-9.85%) |
| Aug 22, 2025 | 130 | -8.66 (-6.25%) |
| Aug 29, 2025 | 125 | -13.66 (-9.85%) |
| Sep 5, 2025 | 131 | -7.66 (-5.53%) |
| Sep 12, 2025 | 135 | -3.66 (-2.64%) |
| Sep 19, 2025 | 120 | -18.66 (-13.46%) |
| Sep 26, 2025 | 135 | -3.66 (-2.64%) |
| Oct 17, 2025 | 130 | -8.66 (-6.25%) |
| Jan 16, 2026 | 120 | -18.66 (-13.46%) |
| Mar 20, 2026 | 130 | -8.66 (-6.25%) |
| Apr 17, 2026 | 65 | -73.66 (-53.12%) |
| Jun 18, 2026 | 130 | -8.66 (-6.25%) |
| Sep 18, 2026 | 135 | -3.66 (-2.64%) |
| Dec 18, 2026 | 145 | 6.34 (4.57%) |
| Jan 15, 2027 | 130 | -8.66 (-6.25%) |